Overview

Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer

Status:
Unknown status

Trial end date:
2019-07-01

Target enrollment:

Participant gender:

Summary

The primary objective is to compare neo-adjuvant chemoradiotherapy followed by Mckeown Minimally Invasive Esophagectomy (MIE) Versus Mckeown MIE, pure radical chemoradiotherapy in terms of the overall survival time (OS) in patients with Stage IIB or III squamous cell esophageal carcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Chengchu Zhu

Collaborators:

Fudan University
Sun Yat-sen University

Treatments:

Vinorelbine